FinTechFunding

Emyria: Expands drug candidate library with fourth batch of MDMA-inspired analogues

Emyria Expands drug candidate library with fourth batch of MDMA-inspired analogues

  • Emyria (EMD) progresses its pre-clinical MDMA-inspired drug discovery program with the University of Western Australia (UWA)
  • The company and UWA have created their fourth batch of 14 novel MDMA analogues, which have been characterised and sent for safety screening
  • With this fourth batch, the company’s product library now comprises over 140 neurologically active compounds
  • The company has shipped five priority compounds to PsychoGenics in the US for advanced preclinical screening
  • Shares in the company closed grey at 21.5 cents
Previous article
Indiana Resources: Appoints Richard Maish as CEO among board reshuffle
Next article
4DMedical: Receives AMA green light for new CPT code
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NatWest Group Strengthens Free Investment Guidance Programme

New initiative aims to educate more customers on investing.Highlights: NatWest Group expands free investment guidance programme.Initiative targets educating...
FinTech

Tether Launches New Stablecoin Wallet to Enhance User Experience

This innovative platform aims to improve accessibility for crypto users.Highlights: Tether has introduced a new stablecoin wallet.The wallet...
FinTech

FCA Strengthens Money Laundering Combat with Synthetic Dataset

New collaboration aims to enhance detection capabilities against financial crime.Highlights: FCA partners with Turing Institute to combat money...
FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...